Fiasp Insulin Dosing for Adults with Diabetes
Initial Total Daily Dose (TDD)
For adults with type 1 diabetes, start with 0.5 units/kg/day as the total daily dose, with a typical range of 0.4–1.0 units/kg/day depending on metabolic stability and residual endogenous insulin secretion. 1
- In younger patients or those with residual beta-cell function, use the lower end of the range (0.2–0.6 units/kg/day) 1
- For type 2 diabetes patients initiating insulin therapy, begin with basal insulin at 10 units per day or 0.1–0.2 units/kg/day 1
Basal-Bolus Distribution
Allocate approximately 30–50% of the TDD to basal insulin (with recent evidence favoring the lower end), and distribute the remainder as prandial (bolus) insulin across meals. 1
Specific Basal Calculation:
- Basal insulin = 0.47 × TDD (based on optimized pump data) 2
- Alternatively, basal = 0.48 × TDD or approximately 30% of TDD in well-controlled patients 3
Prandial (Bolus) Insulin Initiation:
- When adding prandial insulin to basal therapy, start with 4 units per meal or 10% of the current basal dose, administered with the largest meal 1
- Administer Fiasp 0–2 minutes before the meal (this is critical for Fiasp's faster onset) 4
Insulin-to-Carbohydrate Ratio (ICR)
Calculate the insulin-to-carbohydrate ratio using ICR = 300/TDD for breakfast, or ICR = 400/TDD for lunch and dinner. 3
- The traditional 500 rule (ICR = 500/TDD) underestimates insulin needs when basal rates are properly optimized 3
- ICR has diurnal variation, with breakfast requiring more insulin per gram of carbohydrate 3
- Alternative formula: ICR = 2.8 × body weight (lb) / TDD 2
Correction Factor (CF)
Calculate the correction factor as CF = 1,700/TDD or CF = 1,500/TDD. 2, 5
- The 1,700 rule is supported by data from well-controlled patients 2
- The 1,500 rule is an alternative validated formula 5
- These formulas provide the drop in blood glucose (mg/dL) expected from 1 unit of insulin 2
Titration Strategy
Basal Insulin Titration:
- Increase basal by 2 units every 3 days until fasting plasma glucose reaches the individualized target, provided no hypoglycemia occurs 1
- Target fasting glucose: 80–130 mg/dL (4.4–7.2 mmol/L) 6
Prandial Insulin Titration:
- Adjust prandial doses by 1–2 units or 10–15% of the current dose based on post-prandial glucose responses 1
- Monitor glucose 2 hours post-meal; target is within 20% of pre-meal glucose or 80–120 mg/dL 5
Hypoglycemia Management
If hypoglycemia occurs without an obvious cause, reduce the corresponding insulin dose (basal or prandial) by 10–20%. 6, 1
- For severe hypoglycemia on basal insulin, reduce basal by 10–20% immediately (e.g., from 19 U to 15–17 U) 6
- Treat conscious hypoglycemia with 15–20 g fast-acting carbohydrate; recheck in 15 minutes 6
- Prescribe glucagon for all patients initiating insulin therapy 1
Fiasp-Specific Pharmacodynamics
Fiasp has a faster onset than standard insulin aspart, with measurable glucose-lowering beginning at approximately 16–20 minutes and peak effect at 91–133 minutes depending on dose. 4
- Duration of action: 5–7 hours depending on dose 4
- This faster onset necessitates administration 0–2 minutes before meals rather than the traditional 15-minute pre-meal timing 4
Practical Example Calculation
For a 70 kg adult with type 1 diabetes:
- TDD = 0.5 × 70 kg = 35 units/day
- Basal insulin = 0.47 × 35 = 16.5 units/day (or 30% = 10.5 units if using lower ratio)
- Prandial insulin pool = 35 – 16.5 = 18.5 units/day (divided among meals)
- ICR (breakfast) = 300/35 = 8.6 g carb per unit
- ICR (lunch/dinner) = 400/35 = 11.4 g carb per unit
- Correction factor = 1,700/35 = 49 mg/dL drop per unit
Critical Pitfalls to Avoid
- Do not use the traditional 50% basal/50% bolus split—recent evidence shows 30–47% basal is more appropriate in well-controlled patients 1, 2, 3
- Do not use the 500 rule for ICR—it underestimates insulin needs; use 300/TDD or 400/TDD instead 3
- Do not delay Fiasp administration—it must be given 0–2 minutes before eating, not 15 minutes before 4
- Do not postpone dose adjustments—titrate systematically every 3 days rather than waiting weeks 1
- Do not ignore renal impairment—in patients with eGFR <60 mL/min, reduce basal to 0.1–0.2 units/kg/day 6
Monitoring Requirements
- Check fasting blood glucose daily during titration 6
- Monitor glucose at the time of previous hypoglycemia if applicable 6
- Reassess glycemic control every 3–6 months minimum to prevent therapeutic inertia 1
- Watch for signs of over-basalization: large bedtime-to-morning glucose differential, hypoglycemia, or high glucose variability 1